An investigational medication designated TAS-303 shows efficacy and safety in treatment of women with stress urinary incontinence (SUI), reports a placebo-controlled clinical trial in the August issue... Stay informed with the latest. |
Evanilson:... ’noisses gniniart eht hsinif tRipple:... )DSU-PRX( )edargpU( tsylataC hFlorence-like... 2£ rof reeb fo tnip a teg nacBank... tsacerof spot ,selbuod naht erThe... gnirongi ylegral si EGOD tahtManchester's... aera eno no gib gnitteb si inuBCH... slaicnivorp ta tops a nrae sgoEveryone... recnac nediB revo seiroeht ycaUAAP... diks pans ot PU sepacse nosmadSEC... sotpA htiw srentrap tfosorciM